We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBS icon
451
HubSpot
HUBS
$12.9B
$2.59M 0.01%
5,544
+868
+19% +$437K
SPG icon
452
Simon Property Group
SPG
$76.4B
$2.59M 0.01%
13,798
-14,048
-50% -$2.43M
CHRW icon
453
C.H. Robinson
CHRW
$20.5B
$2.56M 0.01%
19,367
+2,103
+12% +$247K
ERII icon
454
Energy Recovery
ERII
$420M
$2.52M 0.01%
163,157
DAR icon
455
Darling Ingredients
DAR
$9.32B
$2.51M 0.01%
81,228
-1,078
-1% -$36K
ITRI icon
456
Itron
ITRI
$4.48B
$2.49M 0.01%
19,974
K
457
DELISTED
Kellanova
K
$2.48M 0.01%
30,207
+3,653
+14% +$291K
EQR icon
458
Equity Residential
EQR
$25.8B
$2.45M 0.01%
37,908
-308
-0.8% -$20.1K
CW icon
459
Curtiss-Wright
CW
$25.1B
$2.43M 0.01%
4,478
+2,998
+203% +$1.48M
NRIX icon
460
Nurix Therapeutics
NRIX
$2.45B
$2.42M 0.01%
262,384
FANG icon
461
Diamondback Energy
FANG
$56B
$2.39M 0.01%
16,679
+1,408
+9% +$200K
LPLA icon
462
LPL Financial
LPLA
$27B
$2.38M 0.01%
7,166
+295
+4% +$107K
CTRA
463
DELISTED
Coterra Energy
CTRA
$2.38M 0.01%
100,782
+66,676
+195% +$1.61M
KVUE icon
464
Kenvue
KVUE
$38B
$2.38M 0.01%
146,854
-11,468
-7% -$234K
SFM icon
465
Sprouts Farmers Market
SFM
$7.44B
$2.38M 0.01%
21,848
-10,758
-33% -$1.57M
KHC icon
466
Kraft Heinz
KHC
$32.8B
$2.36M 0.01%
90,770
-2,780
-3% -$75.5K
CTVA icon
467
Corteva
CTVA
$60.5B
$2.35M 0.01%
34,794
-415
-1% -$30.1K
MAS icon
468
Masco
MAS
$14.3B
$2.34M 0.01%
33,190
+18,200
+121% +$1.28M
HPE icon
469
Hewlett Packard
HPE
$58.8B
$2.32M 0.01%
94,500
EFX icon
470
Equifax
EFX
$22B
$2.31M 0.01%
8,989
-537
-6% -$135K
TXT icon
471
Textron
TXT
$14.7B
$2.25M 0.01%
26,647
+8,174
+44% +$666K
RDDT icon
472
Reddit
RDDT
$34.3B
$2.18M 0.01%
9,477
+2,391
+34% +$488K
DOC icon
473
Healthpeak Properties
DOC
$15.5B
$2.18M 0.01%
113,654
-12,557
-10% -$225K
CSGP icon
474
CoStar Group
CSGP
$12.2B
$2.16M 0.01%
25,644
+6,006
+31% +$531K
IBKR icon
475
Interactive Brokers
IBKR
$38.4B
$2.13M 0.01%
30,909
+3,437
+13% +$216K

Similar funds

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.